Recent Advancements in Tuberculosis Drug Discovery (eBook)

Artikelnummer: 978-1-040-81255-6
Einband: Adobe Digital Editions
Verfügbarkeit: Download, sofort verfügbar (Link per E-Mail)
CHF 310.90
decrease increase

Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.

The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.

Tuberculosis is a major global health threat even today, claiming the lives of millions each year, despite the availability of effective treatments for the disease. The emergence of drug resistance and limitations of existing therapies demand the continuous development of new and improved drugs. This new book provides a comprehensive overview of the latest progress in this field, covering state-of-the-art approaches to untangle the complexities of drug resistance.

The book explores diagnosis methods, drug resistance mechanisms, and limitations in existing drugs and proposes strategies such as structural modifications, efflux pathway targeting, and host-directed therapies to overcome resistance. It also looks at artificial intelligence for TB management. Recent advancements in tuberculosis control, vaccine development, and biomarkers are also covered along with visions for the future of TB drug discovery, offering a glimpse into the evolving landscape of combating tuberculosis.

Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagTaylor & Francis Ebooks
EinbandAdobe Digital Editions
Erscheinungsjahr2025
Seitenangabe462 S.
AusgabekennzeichenEnglisch
Abbildungen64 schwarz-weiße und 15 farbige Abbildungen, 1 schwarz-weiße und 1 farbige Fotos, 63 schwarz-weiße und 14 farbige Zeichnungen, 28 schwarz-weiße Tabellen
Masse26'761 KB
PlattformEPUB
AutorChavda, Vivek P. (Hrsg.) / Chhabria, Mahesh T. (Hrsg.) / Teli, Divya M. (Hrsg.)

Über den Autor Vivek P. (Hrsg.) Chavda

Vivek P. Chavda, MPharm, is an Assistant Professor in the Department of Pharmaceutics and Pharmaceutical Technology at the L. M. College of Pharmacy, India. Before joining academia, he served in the biologics industry for almost eight years in research and development with two successful regulatory filings at Lupin Biotech (Pune) and Dr. Reddy's Laboratory (Hyderabad). He has to his credit more than 250 national and international publications, including book chapters, books, as well as numerous newsletter articles. He also has seven patents in progress. His research interests include development of biologics processes and formulations, medical device development, nano-diagnostics, long-acting parenteral formulations, and nano-vaccines. He has been listed among the World's Top 2% Scientists by Stanford University, USA, for 2023 and 2024.

Weitere Titel von Vivek P. (Hrsg.) Chavda

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten